poisar

Stock

Labcorp Holdings Inc. LH

$320.18-0.75%

Overview

LH market data

Price History

LH price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
26.17
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$10.46
Diluted earnings per share over the trailing twelve months.
Beta
0.86
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
0.9%
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
7.0%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$244.52 – $323.97
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $26.2B · P/B 2.41 · P/S 1.83.

Company News

10 captured
8-K filing — LABCORP HOLDINGS INC. (LH)SEC EDGAR · Aug 14, 2026, 12:55 PM
Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 MillionThe Motley Fool · Aug 12, 2026, 10:15 PM
Labcorp Announces FDA Approval Of PGDx elio Tissue Complete CDx As Companion Diagnostic To Identify Advanced Melanoma Patients With BRAF V600E/K VariantsBenzinga · Aug 10, 2026, 11:14 AM
Labcorp Announces Availability of Roche's Ventana Pten RxDx Assay, First Immunohistochemistry Companion Diagnostic Test Approved By FDA To Determine Pten Protein Loss In Prostate Adenocarcinoma PatientsBenzinga · Aug 4, 2026, 11:13 AM
JP Morgan Maintains Overweight on Labcorp Holdings, Raises Price Target to $360Benzinga · Aug 3, 2026, 3:36 PM
Morgan Stanley Maintains Overweight on Labcorp Holdings, Raises Price Target to $338Benzinga · Jul 31, 2026, 5:33 PM
Truist Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $350Benzinga · Jul 31, 2026, 1:17 PM
Barclays Maintains Equal-Weight on Labcorp Holdings, Raises Price Target to $320Benzinga · Jul 31, 2026, 12:01 PM
Labcorp Holdings Raises FY2026 Adj EPS Guidance from $17.70-$18.35 to $18.10-$18.55 vs $18.01 Est; Raises FY2026 Sales Guidance from $14.650B-$14.800B to $14.710B-$14.827B vs $14.707B EstBenzinga · Jul 30, 2026, 10:51 AM
Laboratory Corp Q2 Adj. EPS $4.99 Beats $4.78 Estimate, Sales $3.731B Beat $3.711B EstimateBenzinga · Jul 30, 2026, 10:50 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock